FDA Approved: KLISYRI — Original Application (Almirall, LLC)

View source ↗

Summary

The FDA approved KLISYRI (tirbanibulin) 1% topical cream under its original application (NDA213189) from Almirall. It is indicated for actinic keratosis of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• KLISYRI (tirbanibulin)

Snippet

ORIG AP for KLISYRI (TIRBANIBULIN)